Literature DB >> 17426876

Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs.

Paulo M M Guedes1, Vanja M Veloso, Marcelo V Caliari, Cláudia M Carneiro, Sheler M Souza, Marta de Lana, Egler Chiari, Maria T Bahia, Lúcia M C Galvão.   

Abstract

Trypanosoma cruzi is a hemoflagelate parasite associated with heart dysfunctions causing serious problems in Central and South America. Beagle dogs develop the symptoms of Chagas disease in humans, and could be an important experimental model for better understanding the immunopathogenic mechanisms involved in the chagasic infection. In the present study we investigated the relation among biological factors inherent to the parasite (trypomastigote polymorphism and in vitro infectivity) and immunoglobulin production, inflammation, and fibrosis in the heart of Beagle dogs infected with either T. cruzi Y or Berenice-78 strains. In vitro infectivity of Vero cells as well as the extension of cardiac lesions in infected Beagle was higher for Y strain when compared to Berenice-78 strain. These data suggested that in vitro infectivity assays may correlate with pathogenicity in vivo. In fact, animals infected with Y strain, which shows prevalence of slender forms and high infectivity in vitro, presented cardiomegaly, inflammation, and fibrosis in heart area. Concerning the immunoglobulin production, no statistically significant difference was observed for IgA, IgM or IgG levels among T. cruzi infected animals. However, IgA together IgM levels have shown to be a good marker for the acute phase of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426876     DOI: 10.1590/s0074-02762007005000003

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  13 in total

Review 1.  Immunoregulatory networks in human Chagas disease.

Authors:  W O Dutra; C A S Menezes; L M D Magalhães; K J Gollob
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

2.  Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.

Authors:  Paulo M M Guedes; Fabiana S Oliveira; Fredy R S Gutierrez; Grace Kelly da Silva; Gerson Jhonatan Rodrigues; Lusiane Maria Bendhack; Douglas W Franco; Maria A Do Valle Matta; Dario S Zamboni; Roberto Santana da Silva; João Santana Silva
Journal:  Br J Pharmacol       Date:  2010-01-27       Impact factor: 8.739

3.  Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity.

Authors:  Jean Jerley Nogueira Silva; Paulo Marcos Matta Guedes; Aderson Zottis; Tatiane Luciano Balliano; Francisco Ordelei Nascimento Silva; Luiz Gonzaga França Lopes; Javier Ellena; Glaucius Oliva; Adriano Defini Andricopulo; Douglas Wagner Franco; João Santana Silva
Journal:  Br J Pharmacol       Date:  2010-01-26       Impact factor: 8.739

4.  Evaluation of clinical and immunopathological features of different infective doses of Trypanosoma cruzi in dogs during the acute phase.

Authors:  Israel A Quijano-Hernández; Alejandro Castro-Barcena; Esteban Aparicio-Burgos; Marco A Barbosa-Mireles; Julio V Cruz-Chan; Juan C Vázquez-Chagoyán; Manuel E Bolio-González; Eric Dumonteil
Journal:  ScientificWorldJournal       Date:  2012-04-01

5.  Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.

Authors:  José E Aparicio-Burgos; Laucel Ochoa-García; José Antonio Zepeda-Escobar; Shivali Gupta; Monisha Dhiman; José Simón Martínez; Roberto Montes de Oca-Jiménez; Margarita Val Arreola; Alberto Barbabosa-Pliego; Juan C Vázquez-Chagoyán; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

6.  Host-Parasite Interactions in Chagas Disease: Genetically Unidentical Isolates of a Single Trypanosoma cruzi Strain Identified In Vitro via LSSP-PCR.

Authors:  Nívia Carolina Nogueira-Paiva; Paula Melo de Abreu Vieira; Larissa Maris Rezende Oliveri; Kátia da Silva Fonseca; Gwenaelle Pound-Lana; Maykon Tavares de Oliveira; Marta de Lana; Vanja Maria Veloso; Alexandre Barbosa Reis; Washington Luiz Tafuri; Cláudia Martins Carneiro
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

7.  Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.

Authors:  Olivia Rodríguez-Morales; Silvia C Carrillo-Sánchez; Humberto García-Mendoza; Alberto Aranda-Fraustro; Martha A Ballinas-Verdugo; Ricardo Alejandre-Aguilar; José Luis Rosales-Encina; Maite Vallejo; Minerva Arce-Fonseca
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

8.  Myenteric plexus is differentially affected by infection with distinct Trypanosoma cruzi strains in Beagle dogs.

Authors:  Nívia Carolina Nogueira-Paiva; Kátia da Silva Fonseca; Paula Melo de Abreu Vieira; Lívia Figueiredo Diniz; Ivo Santana Caldas; Sandra Aparecida Lima de Moura; Vanja Maria Veloso; Paulo Marcos da Matta Guedes; Washington Luiz Tafuri; Maria Terezinha Bahia; Cláudia Martins Carneiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11-04       Impact factor: 2.743

9.  Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma cruzi-Infected Dogs.

Authors:  Guilherme de Paula Costa; Laís Roquete Lopes; Maria Cláudia da Silva; Aline Luciano Horta; Washington Martins Pontes; Cristiane M Milanezi; Paulo Marcos da Mata Guedes; Wanderson Geraldo de Lima; Richard Schulz; João Santana da Silva; Andre Talvani
Journal:  Mediators Inflamm       Date:  2016-09-01       Impact factor: 4.711

10.  Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients.

Authors:  Nathalie de Sena Pereira; Tamyres Bernadete Dantas Queiroga; Daniela Ferreira Nunes; Cléber de Mesquita Andrade; Manuela Sales Lima Nascimento; Maria Adelaide Do-Valle-Matta; Antônia Cláudia Jácome da Câmara; Lúcia Maria da Cunha Galvão; Paulo Marcos Matta Guedes; Egler Chiari
Journal:  PLoS Negl Trop Dis       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.